Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:51 PM
Ignite Modification Date: 2025-12-25 @ 5:26 PM
NCT ID: NCT00223704
Description: None
Frequency Threshold: 5
Time Frame: Hospitalization
Study: NCT00223704
Study Brief: Bradykinin Receptor Antagonism During Cardiopulmonary Bypass
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo Group Placebo was normal saline None None 1 38 15 38 View
Aminocaproic Acid Group Aminocaproic acid is an antifibrinolytic drug None None 1 37 11 37 View
HOE 140 Group Bradykinin B2 receptor antagonist None None 1 40 18 40 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Re-exploration for bleeding SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Acute kidney injury SYSTEMATIC_ASSESSMENT Renal and urinary disorders None View
New onset postoperative atrial fibrillation SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Placement of permanent pacemaker SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Prolonged Mechanical Ventilation (>24 hours) SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View